Progyny

Progyny EBIT

The EBIT of Progyny (PGNY) as of Nov 12, 2026 is 85.28 M USD. In the previous year, EBIT was 67.46 M USD — a change of 26.42% (higher).

EBIT

85.28 MUSD

YoY

26.42%

Last updated:

In 2025, Progyny's EBIT was 85.28 M USD, a 26.42% increase from the 67.46 M USD EBIT recorded in the previous year.

The Progyny EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
62.18 M USD
Jan 1, 2024
67.46 M USD
Jan 1, 2025
85.28 M USD
Jan 1, 2026 (e)
141.83 M USD
Jan 1, 2027 (e)
172.29 M USD
Jan 1, 2028 (e)
197.48 M USD
Jan 1, 2029 (e)
214.10 M USD
Jan 1, 2030 (e)
209.42 M USD
The Progyny EBIT history
YEAREBITYoY
est209.42 MUSD-2.18%
est214.10 MUSD+8.42%
est197.48 MUSD+14.62%
est172.29 MUSD+21.47%
est141.83 MUSD+66.32%
85.28 MUSD+26.42%
67.46 MUSD+8.48%
62.18 MUSD+166.42%
23.34 MUSD-27.83%
32.34 MUSD+287.40%
8.35 MUSD-13.73%
9.68 MUSD-251.30%
-6.40 MUSD-45.42%
-11.72 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Progyny Revenue

Progyny Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.08 B USD
62.18 M USD
62.04 M USD
Jan 1, 2024
1.17 B USD
67.46 M USD
54.34 M USD
Jan 1, 2025
1.29 B USD
85.28 M USD
58.52 M USD
Jan 1, 2026 (e)
1.38 B USD
141.83 M USD
113.54 M USD
Jan 1, 2027 (e)
1.53 B USD
172.29 M USD
137.59 M USD
Jan 1, 2028 (e)
1.65 B USD
197.48 M USD
159.60 M USD
Jan 1, 2029 (e)
1.64 B USD
214.10 M USD
170.98 M USD
Jan 1, 2030 (e)
1.71 B USD
209.42 M USD
167.25 M USD

Progyny Margins

Progyny stock margins

The Progyny margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Progyny. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Progyny.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
22.05 %
5.74 %
5.73 %
Jan 1, 2024
21.71 %
5.78 %
4.66 %
Jan 1, 2025
23.63 %
6.62 %
4.54 %
Jan 1, 2026 (e)
23.63 %
10.30 %
8.25 %
Jan 1, 2027 (e)
23.63 %
11.23 %
8.97 %
Jan 1, 2028 (e)
23.63 %
11.96 %
9.67 %
Jan 1, 2029 (e)
23.63 %
13.02 %
10.40 %
Jan 1, 2030 (e)
23.63 %
12.27 %
9.80 %

Progyny Stock analysis

What does Progyny do? Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Progyny's EBIT

Progyny's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Progyny's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Progyny's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Progyny’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Progyny stock

EBIT of Progyny is 85.28 M USD in 2025.

EBIT of Progyny changed from 67.46 M USD to 85.28 M USD, representing a 26.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Progyny since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Progyny historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Progyny

All Key Metrics — Progyny